Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Investigating tropical enteropathy as a cause of oral rotavirus vaccine failure in the developing world

FY 2013-14

Summary
One of the main causes of childhood death in developing nations is diarrheal disease, usually initiated by exposure to infectious agents such as rotavirus. There are two main oral vaccines available for rotavirus immunization. Although they are very effective in Canada, their success rate is very low in developing countries (50-75%). It is currently not known why the same vaccine and vaccination strategy is less effective in the developing world. One hypothesis is that tropical enteropathy, a condition triggered by unhygienic environments and causes intestinal problems and malnutrition, results in poor uptake of oral vaccines. To address this, we have commenced a study to examine the immune responses of rotavirus vaccinated and unvaccinated infants in Bangladesh and India. We will identify the vaccinated infants who responded well to the vaccine and those who did not based on whether they got rotavirus-induced diarrhea. We will look at the white blood cells responsible for responding to rotavirus infections in these two groups, and search for differences in their magnitude, function, or location. These factors may be able to explain why some infants are not effectively vaccinated. Once we have this information, we will then correlate their immune response to rotavirus vaccine with measures of tropical enteropathy (nutritional status, permeability of the intestinal tract, and evidence of bacteria in the blood stream). If we find that tropical enteropathy is correlated with rotavirus vaccine failure, the next step would be to treat infants for tropical enteropathy symptoms (e.g. nutritional supplements), alter the route of immunization, or to provide adjuvants (immunogenic materials) in the vaccine. These data would provide advances for the development of many other oral vaccines for infants worldwide.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
300341
Name
Wagar Lisa E
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigating tropical enteropathy as a cause of oral rotavirus vaccine failure in the developing world
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Gastrointestinal Disease; Oral Vaccine Failure; Pediatric Vaccination; Phosphoflow; Rotavirus; Time-Of-Flight Mass Cytometry; Tropical Enteropathy; Viral Immunology
Abstract
One of the main causes of childhood death in developing nations is diarrheal disease, usually initiated by exposure to infectious agents such as rotavirus. There are two main oral vaccines available for rotavirus immunization. Although they are very effective in Canada, their success rate is very low in developing countries (50-75%). It is currently not known why the same vaccine and vaccination strategy is less effective in the developing world. One hypothesis is that tropical enteropathy, a condition triggered by unhygienic environments and causes intestinal problems and malnutrition, results in poor uptake of oral vaccines. To address this, we have commenced a study to examine the immune responses of rotavirus vaccinated and unvaccinated infants in Bangladesh and India. We will identify the vaccinated infants who responded well to the vaccine and those who did not based on whether they got rotavirus-induced diarrhea. We will look at the white blood cells responsible for responding to rotavirus infections in these two groups, and search for differences in their magnitude, function, or location. These factors may be able to explain why some infants are not effectively vaccinated. Once we have this information, we will then correlate their immune response to rotavirus vaccine with measures of tropical enteropathy (nutritional status, permeability of the intestinal tract, and evidence of bacteria in the blood stream). If we find that tropical enteropathy is correlated with rotavirus vaccine failure, the next step would be to treat infants for tropical enteropathy symptoms (e.g. nutritional supplements), alter the route of immunization, or to provide adjuvants (immunogenic materials) in the vaccine. These data would provide advances for the development of many other oral vaccines for infants worldwide.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wagar, Lisa E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2013-14) | Canada Spends